Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 57

Sort by

Sort Order Select

Journal Articles

Effectiveness of Prophylaxis with Granulocyte Colony-Stimulating Factor Among Cancer Patients Receiving Myelosuppressive Chemotherapy in US Clinical Practice

Kathryn Richert-Boe, MD MPH, Lois Lamerato, PhD, Gary H. Lyman, MD MPH, Manpreet Kaur, MPH, MBA, Neel Shah, BPharm, PhD, Tatiana Lawrence, MD, Devi Sundaresan, MS, Amanda Silvia, BS, Ahuva Hanau, BS, Derek Weycker, PhD

Blood (2019) 134 (Supplement_1): 4688.

https://doi.org/10.1182/blood-2019-123559

Published: 2019

Journal Articles

Incidence of Second Primary Malignancies and Association with Treatment in US Veterans with Multiple Myeloma

Nathanael Fillmore, PhD, Sarvari Venkata Yellapragada, MD, Cenk Yildirim, MS, Aimaz Afrough, MD, Adanma Anji Ayanambakkam Attanathi, MD, Ifeorah Chizoba, MPH, Nhan Do, MD, Mary Brophy, MD MPH, Nikhil C. Munshi, MD

Blood (2019) 134 (Supplement_1): 1806.

https://doi.org/10.1182/blood-2019-132227

Published: 2019

Journal Articles

In-Hospital Mortality and Morbidity Among Patients Presenting with Intracranial Hemorrhage: A Single Center's Experience with Vitamin K Antagonists and the Direct Oral Anticoagulants

Christopher Cipkar, MD BSc, Sujitha Srinathan, Philip Chiang, BMSc, Lana A Castellucci, MD FRCPC, MSc

Blood (2019) 134 (Supplement_1): 3668.

https://doi.org/10.1182/blood-2019-131769

Published: 2019

Journal Articles

Health Care Costs Associated with Contemporary Chronic Myelogenous Leukemia (CML) Therapy Compared to Other Hematologic Malignancies (HEM)

Jennifer J. Wilkes, MDMSCE, Gary H. Lyman, MD MPH, David R Doody, MS, Shasank R Chennupati, PharmD, MPH, Laura Becker, MS, Pamela E Morin, Lena E. Winestone, MD MSHP, Henry (Joe) Henk, PhD, Eric J Chow, MD MPH

Blood (2019) 134 (Supplement_1): 4753.

https://doi.org/10.1182/blood-2019-124106

Published: 2019

Journal Articles

A Retrospective Chart Review to Assess Indications, Risk Factors and Complications Associated with the Use of Indwelling Catheters in Pediatric Patients with Sickle Cell Disease - a Single Institution Experience

Chibuzo Ilonze, MD, Michael P Anderson, PhD, Alexander Stubblefield, Janna M. Journeycake, MD, Arpan Sinha, MBBS, MD

Blood (2019) 134 (Supplement_1): 4856.

https://doi.org/10.1182/blood-2019-130467

Published: 2019

Journal Articles

Heavy Menstrual Bleeding Under-Recognized in Menstruating Women Treated with Oral Anticoagulants

Vivia Chi, MDcal Student, Maureen Baldwin, MD, Bethany T. Samuelson Bannow, MD

Blood (2019) 134 (Supplement_1): 60.

https://doi.org/10.1182/blood-2019-131026

Published: 2019

Journal Articles

With Equal Access, African Americans with Non-del17p Multiple Myeloma Have Superior Overall Survival, but del17p Still Carries Poor Prognosis across Race: A VA Study

Anusha Munjuluri, MSc, Nathanael Fillmore, PhD, Diana Cirstea, MD, Hassan Yameen, MD, Sarvari Venkata Yellapragada, MD, Ifeorah Chizoba, MPH, Nhan Do, MD, Mary Brophy, MD MPH, Nikhil C. Munshi, MD

Blood (2019) 134 (Supplement_1): 4388.

https://doi.org/10.1182/blood-2019-131247

Published: 2019

Journal Articles

Predictors of Febrile Neutropenia Among Cancer Patients Receiving Myelosuppressive Chemotherapy in US Clinical Practice

Gary H. Lyman, MD MPH, Kathryn Richert-Boe, MD MPH, Lois Lamerato, PhD, Manpreet Kaur, MPH, MBA, Neel Shah, BPharm, PhD, Tatiana Lawrence, MD, Devi Sundaresan, MS, Amanda Silvia, BS, Ahuva Hanau, BS, Derek Weycker, PhD

Blood (2019) 134 (Supplement_1): 5854.

https://doi.org/10.1182/blood-2019-123524

Published: 2019

Journal Articles

Platelet Trends Are Not Predictive of Heparin Induced Thrombocytopenia in Patients on Extra Corporeal Membrane Oxygenation

Daniel Stapor, Anil Rengan, MD, Mark Weiner, MD, Huaqing Zhao, MS, PhD, Nadia Ali, MD

Blood (2018) 132 (Supplement 1): 3767.

https://doi.org/10.1182/blood-2018-99-115396

Published: 2018

Journal Articles

Management of Cerebral Vein Thrombosis in a Canadian Tertiary Hospital

Lana A Castellucci, MD, Philip Chiang

Blood (2018) 132 (Supplement 1): 2532.

https://doi.org/10.1182/blood-2018-99-118369

Published: 2018

Journal Articles

Cost of Care at NCI-Designated Comprehensive Cancer Centers Vs. Other Treatment Sites for Young Adults with Newly-Diagnosed Acute Lymphoblastic Leukemia (ALL)

Julie A. Wolfson, MD MS, Smita Bhatia, MD MPH, Jill Ginsberg, MD, Laura Becker, MS, David Bernstein, Henry (Joe) Henk, PhD, Gary H. Lyman, MD MPH, FRCP, Paul Nathan, MD, Diane Puccetti, MD, Jennifer J. Wilkes, MD, Lena E. Winestone, MD, Kelly Kenzik, PhD

Blood (2018) 132 (Supplement 1): 3531.

https://doi.org/10.1182/blood-2018-99-110649

Published: 2018

Journal Articles

Outcomes of Direct Oral Anticoagulant- and Warfarin-Associated Hemorrhage: A Single Center Retrospective Cohort Study

Lorraine Cafuir, MD, En Cheng, Christine L Kempton, MD MSc

Blood (2018) 132 (Supplement 1): 826.

https://doi.org/10.1182/blood-2018-99-110685

Published: 2018

Journal Articles

Changes in Imaging Surveillance of Diffuse Large B-Cell Lymphoma Survivors after Publication of the American Society of Hematology Choosing Wisely ® Recommendations

Urshila Durani, MD, Dennis Asante, MS, Herbert C Heien, MS, Carrie A. Thompson, MD, Thorvardur R. Halfdanarson, MD, Prema Peethambaram, MBBS, J. Fernando Quevedo, MD, Jose C Villasboas, Ronald S. Go, MD

Blood (2018) 132 (Supplement 1): 618.

https://doi.org/10.1182/blood-2018-99-119179

Published: 2018

Journal Articles

Factors Associated with Overall Survival in Follicular Lymphoma Patients Who Are Eligible for Maintenance Therapy

Ahmad S Halwani, MD, Kelli M Rasmussen, MS, Vikas Patil, MS, Zachary Burningham, PhD, Catherine Li, PhD, Christina Young, MA, Anthony Masaquel, PhD MPH, Kevin Henderson, PharmD, MBA, Elisha Delong-Sieg, PharmD, Brian C Sauer, PhD

Blood (2018) 132 (Supplement 1): 4159.

https://doi.org/10.1182/blood-2018-99-115722

Published: 2018

Journal Articles

Treatment Practices and Outcomes in Older Adults with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated in the Veterans Health Administration

Ahmad S Halwani, MD, Kelli M Rasmussen, MS, Vikas Patil, MS, Catherine Li, PhD, Christina Young, MA, Zachary Burningham, PhD, Mathias Schulz, MD MBA, Jia Li, PhD, Anthony Masaquel, PhD MPH, Mary Halloran, PharmD, Elisha Delong-Sieg, PharmD, Brian C Sauer, PhD

Blood (2018) 132 (Supplement 1): 4205.

https://doi.org/10.1182/blood-2018-99-116695

Published: 2018

Journal Articles

Outcomes in the Secondary Prevention of Cerebral Venous Thrombosis in Cancer Only Population

Nadia Isabel Abelhad, MDBS

Blood (2018) 132 (Supplement 1): 5063.

https://doi.org/10.1182/blood-2018-99-110298

Published: 2018

Journal Articles

Clinical Outcomes and Cost Analysis of Dose-Adjusted R-EPOCH Vs R-CHOP in Treatment of Diffuse Large B- Cell Lymphoma with High Risk Features

Bhagirathbhai Dholaria, MBBS, Prakash Vishnu, MD, Yenni Alejandro Moreno-Vanegas, Aaron C. Spaulding, Nancy N. Diehl, David Hodge, Candido E. Rivera, MD, Han Tun, MD

Blood (2018) 132 (Supplement 1): 4790.

https://doi.org/10.1182/blood-2018-99-117743

Published: 2018

Journal Articles

Cancer Incidence in Sickle Cell Disease:an Institutional Experience

Shivi Jain, MD, Andrew Srisuwananukorn, MD, Santosh L. Saraf, MD, Xu Zhang, PhD, Jin Han, PharmD, PhD, Michel Gowhari, DO, Robert E. Molokie, MD, Victor R. Gordeuk, MD

Blood (2018) 132 (Supplement 1): 1087.

https://doi.org/10.1182/blood-2018-99-115508

Published: 2018

Journal Articles

With Equal Access and Utilization of Resources,Younger African American Patients Have Superior Survival Compared to Caucasian Patients Diagnosed with Multiple Myeloma at the Veterans Affairs Hospitals

Nathanael Fillmore, PhD, Sarvari Venkata Yellapragada, MD, Mehmet Kemal Samur, PhD, Gustavo A. Rivero, MD, Saiju Pyarajan, PhD, Nhan Do, MD, Mary Brophy, MD MPH, Nikhil Munshi, MD

Blood (2018) 132 (Supplement 1): 3191.

https://doi.org/10.1182/blood-2018-99-119490

Published: 2018

Journal Articles

The Engineered MIPI (e-MIPI), a Candidate Data-Mining Based Mantle Cell Lymphoma Prognostic Index Developed from the Dataset of the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial

Blood (2018) 132 (Supplement 1): 2890.

https://doi.org/10.1182/blood-2018-99-114168

Published: 2018

NARROW

Effectiveness of Prophylaxis with Granulocyte Colony-Stimulating Factor Among Cancer Patients Receiving Myelosuppressive Chemotherapy in US Clinical Practice

Incidence of Second Primary Malignancies and Association with Treatment in US Veterans with Multiple Myeloma

In-Hospital Mortality and Morbidity Among Patients Presenting with Intracranial Hemorrhage: A Single Center's Experience with Vitamin K Antagonists and the Direct Oral Anticoagulants

Health Care Costs Associated with Contemporary Chronic Myelogenous Leukemia (CML) Therapy Compared to Other Hematologic Malignancies (HEM)

A Retrospective Chart Review to Assess Indications, Risk Factors and Complications Associated with the Use of Indwelling Catheters in Pediatric Patients with Sickle Cell Disease - a Single Institution Experience

Heavy Menstrual Bleeding Under-Recognized in Menstruating Women Treated with Oral Anticoagulants

With Equal Access, African Americans with Non-del17p Multiple Myeloma Have Superior Overall Survival, but del17p Still Carries Poor Prognosis across Race: A VA Study

Predictors of Febrile Neutropenia Among Cancer Patients Receiving Myelosuppressive Chemotherapy in US Clinical Practice

Platelet Trends Are Not Predictive of Heparin Induced Thrombocytopenia in Patients on Extra Corporeal Membrane Oxygenation

Management of Cerebral Vein Thrombosis in a Canadian Tertiary Hospital

Cost of Care at NCI-Designated Comprehensive Cancer Centers Vs. Other Treatment Sites for Young Adults with Newly-Diagnosed Acute Lymphoblastic Leukemia (ALL)

Outcomes of Direct Oral Anticoagulant- and Warfarin-Associated Hemorrhage: A Single Center Retrospective Cohort Study

Changes in Imaging Surveillance of Diffuse Large B-Cell Lymphoma Survivors after Publication of the American Society of Hematology Choosing Wisely ® Recommendations

Factors Associated with Overall Survival in Follicular Lymphoma Patients Who Are Eligible for Maintenance Therapy

Treatment Practices and Outcomes in Older Adults with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated in the Veterans Health Administration

Outcomes in the Secondary Prevention of Cerebral Venous Thrombosis in Cancer Only Population

Clinical Outcomes and Cost Analysis of Dose-Adjusted R-EPOCH Vs R-CHOP in Treatment of Diffuse Large B- Cell Lymphoma with High Risk Features

Cancer Incidence in Sickle Cell Disease:an Institutional Experience

With Equal Access and Utilization of Resources,Younger African American Patients Have Superior Survival Compared to Caucasian Patients Diagnosed with Multiple Myeloma at the Veterans Affairs Hospitals

The Engineered MIPI (e-MIPI), a Candidate Data-Mining Based Mantle Cell Lymphoma Prognostic Index Developed from the Dataset of the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only